Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Elevation Oncology, Inc. (ELEV)

1.51   0.02 (1.34%) 06-26 23:04
Open: 1.44 Pre. Close: 1.49
High: 1.579 Low: 1.43
Volume: 287,803 Market Cap: 35(M)
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.58 - 1.58 1.58 - 1.59
Low: 1.42 - 1.42 1.42 - 1.43
Close: 1.5 - 1.51 1.51 - 1.52

Technical analysis

as of: 2022-06-24 4:39:32 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.86     One year: 5.38
Support: Support1: 1.2    Support2: 0.99
Resistance: Resistance1: 3.3    Resistance2: 4.61
Pivot: 1.62
Moving Average: MA(5): 1.42     MA(20): 1.8
MA(100): 2.82     MA(250): 6.11
MACD: MACD(12,26): -0.4     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 24.8     %D(3): 19.5
RSI: RSI(14): 34.5
52-week: High: 16.21  Low: 1.2
Average Vol(K): 3-Month: 668 (K)  10-Days: 496 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ELEV ] has closed above bottom band by 41.8%. Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
Hollifield: Elevator rides have their ups and downs - Winston-Salem Journal

Sun, 26 Jun 2022
‘Lift Us Up’ campaign to support elevator at Kingston’s Circle of Friends for the Dying home - The Daily Freeman

Sun, 26 Jun 2022
Willoughby: Elevation, ore and exhausted miners | - The Aspen Times

Thu, 23 Jun 2022
Memorial fund to benefit family of grain elevator victim - WHBF -

Wed, 22 Jun 2022
Activists seize City Hall elevators, demand SRO elevator repairs - Mission Local

Wed, 22 Jun 2022
AEW “Dark: Elevation” Spoilers for 6/27/2022 - Wrestling Headlines

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 23 (M)
Shares Float 8 (M)
% Held by Insiders 2.3 (%)
% Held by Institutions 93.7 (%)
Shares Short 937 (K)
Shares Short P.Month 770 (K)

Stock Financials

EPS -2.5
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.32
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -26.9
Return on Equity (ttm) -45.9
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.91
Qtrly Earnings Growth 0
Operating Cash Flow -35 (M)
Levered Free Cash Flow -19 (M)

Stock Valuations

PE Ratio -0.61
PEG Ratio 0
Price to Book value 0.28
Price to Sales 0
Price to Cash Flow -1.02

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.